Cohance Lifesciences Unveiling the Professional Background of Umang Vohra, Chairman and Group CEO

Cohance Lifesciences Limited has released the professional profile of its Chairman and Group CEO, Mr. Umang Vohra. With over 30 years of extensive experience in the Indian corporate sector, Mr. Vohra brings a wealth of expertise in financial strategy, business planning, and global operations. His leadership journey includes significant tenures at PepsiCo India, Dr. Reddy’s Laboratories, and Cipla Limited, marking a track record of driving transformative growth and global expansion.

Educational Background

Mr. Umang Vohra holds a solid foundation in both technical and management disciplines. He earned his bachelor’s degree in Computer Science engineering from the M.S. Ramaiah Institute of Technology. Furthering his academic credentials, he completed a Master of Business Administration at the T.A. Pai Management Institute, preparing him for high-level strategic roles in the corporate world.

Career Milestones and Strategic Experience

Throughout his three-decade career, Mr. Vohra has held pivotal roles at several major companies:

  • PepsiCo India: Gained foundational expertise in financial strategy and business planning within the global consumer sector.
  • Dr. Reddy’s Laboratories: Served for over 14 years, contributing significantly to the management team as CFO and head of North America generics, where he oversaw key expansion and strategic growth initiatives.
  • Cipla Limited: Spent a decade as Managing Director and Global CEO, leading the organization through a period of transformative growth, global footprint expansion, and the successful execution of critical product launches.

Leadership at Cohance Lifesciences

As the current Chairman and Group CEO, Mr. Vohra leverages his extensive background in navigating complex global markets and managing large-scale enterprise operations to guide Cohance Lifesciences. His proven ability to spearhead national and international initiatives continues to shape the strategic direction and long-term success of the company.

Source: BSE

Previous Article

SBI Card Financial Results for Quarter and Year Ended March 31, 2026

Next Article

Global Health Limited Expands Indore Oncology Footprint with New Hospital Acquisition